CRESEMBA.COM

Antifungal Medication | CRESEMBA® (isavuconazonium sulfate)

Learn more about CRESEMBA® (isavuconazonium sulfate), an FDA‐approved antifungal medication indicated for the treatment of invasive aspergillosis & mucormycosis in adults. Specimens for fungal culture and other relevant laboratory studies (including histopathology) to isolate and identify causative organism(s) should be obtained prior to initiating antifungal therapy. Therapy may be instituted before the results of the cultures and other laboratory studies are known. However, once these results beco

http://www.cresemba.com/

OVERVIEW OF cresemba.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR CRESEMBA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

April

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.4 out of 5 with 10 reviews

5 star

1

4 star

4

3 star

4

2 star

0

1 star

1

Hey there! Start your review of cresemba.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.9 seconds

FAVICON PREVIEW

16x16

CONTACTS AT CRESEMBA.COM

Astellas Pharma Inc.

5-1, Nihon●●●●●●●●●●ho 2-chome

Ch●●ku , Tokyo, 103-8411

JP

81.3●●●●3371

do●●●●●●●@mark-i.jp

View this contact

Astellas Pharma Inc.

5-1, Nihon●●●●●●●●●●ho 2-chome

Ch●●ku , Tokyo, 103-8411

JP

81.3●●●●3371

do●●●●●●●@mark-i.jp

View this contact

Mark-i Inc.

Domain Administrator

2-16-8, Dogenza●●●●●●●●●●●●●●●IP Shibuya Bldg

Shi●●●-ku , Tokyo, 150-0043

JP

81.3●●●●9956

81.3●●●●9930

do●●●●●●●@mark-i.jp

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2013 February 28
UPDATED: 2014 May 26
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

12

YEARS
4

MONTHS
12

DAYS

NAME SERVERS

1: ns1.fujisawa.com
2: ns2.fujisawa.com

REGISTRAR

1 API GMBH

WHOIS : whois.1api.net

REFERRED : http://www.1api.net

CONTENT

PAGES IN
THIS WEBSITE

2

SSL

EXTERNAL LINKS

23

SITE IP

191.238.8.26

LOAD TIME

0.891 sec

SCORE

6.2

PAGE TITLE

Antifungal Medication | CRESEMBA® (isavuconazonium sulfate) | cresemba.com Reviews

<META> DESCRIPTION

Learn more about CRESEMBA® (isavuconazonium sulfate), an FDA‐approved antifungal medication indicated for the treatment of invasive aspergillosis & mucormycosis in adults. Specimens for fungal culture and other relevant laboratory studies (including histopathology) to isolate and identify causative organism(s) should be obtained prior to initiating antifungal therapy. Therapy may be instituted before the results of the cultures and other laboratory studies are known. However, once these results beco

<META> KEYWORDS

1 important safety

2 information

3 prescribing

4 patient

5 request information

6 efficacy

7 invasive aspergillosis

8 invasive mucormycosis

9 safety profile

10 discontinuation rates

CONTENT

Page content here

KEYWORDS ON PAGE

important safety,information,prescribing,patient,request information,efficacy,invasive aspergillosis,invasive mucormycosis,safety profile,discontinuation rates,dosing and administration,storage and handling,pharmacokinetics,drug interactions,menu,cresemba

SERVER

Microsoft-IIS/10.0

POWERED BY

ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Antifungal Medication | CRESEMBA® (isavuconazonium sulfate) | cresemba.com Reviews

https://cresemba.com

Learn more about CRESEMBA® (isavuconazonium sulfate), an FDA‐approved antifungal medication indicated for the treatment of invasive aspergillosis & mucormycosis in adults. Specimens for fungal culture and other relevant laboratory studies (including histopathology) to isolate and identify causative organism(s) should be obtained prior to initiating antifungal therapy. Therapy may be instituted before the results of the cultures and other laboratory studies are known. However, once these results beco

INTERNAL PAGES

cresemba.com

1

Unsubscribe | CRESEMBA® (isavuconazonium sulfate)

https://www.cresemba.com/unsubscribe

Isavuconazonium sulfate) is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults. Usage. Please confirm that you no longer wish to receive communications from Astellas Pharma US, Inc., about CRESEMBA. Isavuconazonium sulfate) by entering your email address below. Please enter a valid email address. Please allow up to 10 days for processing of your request. Return to Home page. IMPORTANT SAFETY INFORMATION AND USE OF CRESEMBA. CRESEMBA shortened the QTc interval in a c...

2

Product Updates & Information | CRESEMBA® (isavuconazonium sulfate)

https://www.cresemba.com/request-information

Isavuconazonium sulfate) is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults. Usage. Request information about CRESEMBA. If you are interested in receiving the latest information about CRESEMBA or would like an Astellas representative to contact you with more information about CRESEMBA, complete the form below. For medical inquiries, contact Medical Communications at 1-800-727-7003. Or email medical.communications@astellas.com. Please make a selection. By providin...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

astellas.us

Astellas Pharma US, Inc. | Products

https://www.astellas.us/therapeutic/product/index.aspx

The Astellas Global Code of Conduct. Policy Summary / Position Statement. Company Facts and Infographics. Astellas Americas Corporate Social Responsibility Report Card. Health is Our Passion and Priority. Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow. US Physician Prescribing Information. US Physician Prescribing Information. For questions...

astellaspharmasupportsolutions.com

Astellas Pharma Support Solutions | Sitemap

http://www.astellaspharmasupportsolutions.com/sitemap.aspx

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? Amphotericin B) liposome for injection. AmBisome Support Solutions Overview. Prior Authorization Assistance Process. Appeals Assistance with Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for AmBisome. Quarterly Coding and Billing Reference Sheets. Billing and Claims Support. Prior...

astellaspharmasupportsolutions.com

Lexiscan Support Solution℠ | Lexiscan® (regadenoson) injection

http://www.astellaspharmasupportsolutions.com/products/lexiscan

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? Lexiscan Support Solutions Overview. Prior Authorization Assistance Process. Appeals Assistance with Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for Lexiscan. Quarterly Coding and Billing Reference Sheets. Application Process for Astellas Access Program.

astellaspharmasupportsolutions.com

Mycamine Support Solutions℠ | MYCAMINE® (micafungin sodium) for injection

http://www.astellaspharmasupportsolutions.com/products/mycamine

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? Prior Authorization Assistance Process. Appeals Assistance With Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for Mycamine. Quarterly Coding and Billing Reference Sheets. Application Process for Astellas Access Program. Indication and Important Safety Information.

astellaspharmasupportsolutions.com

CRESEMBA Support Solutions℠ | CRESEMBA® (isavuconazonium sulfate)

http://astellaspharmasupportsolutions.com/products/cresemba

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? Appeals Assistance with Denied Prior Authorization Requests. Coding and Billing Support. Relevant Codes for CRESEMBA. Quarterly Coding and Billing Reference Sheets. Patient Assistance Eligibility Questions. CRESEMBA Patient Savings Program. Indication and Important Safety Information.

astellaspharmasupportsolutions.com

Mycamine Support Solutions℠ Overview | MYCAMINE® (micafungin sodium) for injection

http://www.astellaspharmasupportsolutions.com/products/mycamine/support_solutions_overview.aspx

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? Prior Authorization Assistance Process. Appeals Assistance With Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for Mycamine. Quarterly Coding and Billing Reference Sheets. Application Process for Astellas Access Program. Indication and Important Safety Information.

astellaspharmasupportsolutions.com

XTANDI Support Solutions℠ Overview | XTANDI® (enzalutamide) capsules

http://www.astellaspharmasupportsolutions.com/products/xtandi/support_solutions_overview.aspx

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? XTANDI Support Solutions Overview. Prior Authorization Assistance Process. Prior Authorization Denial Appeals. Specialty Pharmacies/Dispensing Physician Practices. XTANDI Network Specialty Pharmacies. XTANDI Support Solutions Overview. A component of Astellas Pharma Support Solutions.

astellaspharmasupportsolutions.com

AmBisome Support Solutions℠ Overview | AmBisome® (amphotericin B) liposome for injection

http://www.astellaspharmasupportsolutions.com/products/ambisome/overview.aspx

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? AmBisome Support Solutions Overview. Prior Authorization Assistance Process. Appeals Assistance with Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for AmBisome. Quarterly Coding and Billing Reference Sheets. Application Process for Astellas Access Program.

astellaspharmasupportsolutions.com

ASTAGRAF XL Support Solutions℠ | ASTAGRAF XL® (tacrolimus extended-release capsules)

http://www.astellaspharmasupportsolutions.com/products/astagrafxl

For patients who need. This information is intended for US Healthcare professionals. This information is intended for US residents. Manage access for your patients online. In Search of Support? ASTAGRAF XL Support Solutions Overview. Prior Authorization Assistance Process. Appeals Assistance with Denied Prior Authorization Requests. Billing and Claims Support. Relevant Codes for ASTAGRAF XL. Quarterly Coding and Billing Reference Sheets. ASTAGRAF XL Copay Card. Indication and Important Safety Information.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL LINKS TO THIS WEBSITE

23

OTHER SITES

cresem.es

Home

Ir Arriba / Back To Top. Tel: 34 630 142120. Mission, Vision and Values. This site uses cookies and similar technologies. If you not change browser settings, you agree to it. Learn more. Published: Friday, 18 October 2013 09:56. AVISO LEGAL DE ESTA WEB. Designed by www.diablodesign.eu.

cresem.univ-perp.fr

CRESEM - Accueil CRESEM

30 ans des PUP. Le 19 janvier 2017. CRESEM] Ecocritique et écopoétique. Le 16 décembre 2016. CRESEM] Séminaire : frontières et marchés. Le 14 décembre 2016. CRESEM] Séminaire : Un document très personnel. Le 30 novembre 2016. Nouveau hors-série recherche UPVD. Le 29 novembre 2016. CRESEM] Journée d'étude : Literatura popular i tradicio oral a la Catalunya del Nord. Le 25 novembre 2016. CRESEM] Théâtre, culture et patrimoine en Argentine et Amérique latine. Du 24 novembre 2016 au 25 novembre 2016. Pr&eacu...

cresemba.at

Cresemba SMPC

Isavuconazol (Wirkstoff: Isavuconazoniumsulfat) ist ein intravenöses und orales Breitband-Antimykotikum, das in der Europäischen Union (EU) zugelassen ist für die Behandlung von Erwachsenen mit :. Mukormykose bei Patienten, bei denen eine Behandlung mit Amphotericin B nicht angemessen ist. Um weitere Informationen über CRESEMBA zu erhalten, melden Sie sich bitte mit Ihren DocCheck-Zugangsdaten an. Oder per Telefon (0800-298022). Fachinformation. Stand: Oktober 2015.

cresemba.biz

Registered & Protected by MarkMonitor

This domain is registered and protected. More than half the Fortune 100 trust MarkMonitor. To protect their brands online.

cresemba.co.uk

Cresemba SMPC

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Basilea Pharmaceutica. This site is intended for healthcare. In the United Kingdom. You are now leaving the Basilea Medical Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. Or by phone at (UK) 08001413328.

cresemba.com

Antifungal Medication | CRESEMBA® (isavuconazonium sulfate)

For US. Healthcare Professionals Only. Is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults. Usage. Watch Dr. George Thompson, infectious disease specialist, discuss the clinical efficacy, safety, and dosing regimen for CRESEMBA in the treatment of adult patients with invasive aspergillosis and invasive mucormycosis. Capsules not actual size. Start and stay on. CRESEMBA is available in IV and PO formulations with once-daily maintenance dosing. Coadministration of s...

cresemba.de

Cresemba SMPC

Isavuconazol (Wirkstoff: Isavuconazoniumsulfat) ist ein intravenöses und orales Breitband-Antimykotikum, das in der Europäischen Union (EU) zugelassen ist für die Behandlung von Erwachsenen mit :. Mukormykose bei Patienten, bei denen eine Behandlung mit Amphotericin B nicht angemessen ist. Um weitere Informationen über CRESEMBA zu erhalten, melden Sie sich bitte mit Ihren DocCheck-Zugangsdaten an. Eintritt frei für medizinische Fachkreis. Oder per Telefon (0800-1840212).

cresemba.eu

CRESEMBA EU landing page

This site is intended for healthcare. Professionals outside the US. You are now leaving the Basilea Pharmaceutica Ltd Web site. Basilea offers the link to the following Internet site as a service to the Internet community and is not responsible for any content published on the Web site you are about to enter. Isavuconazole (drug substance: isavuconazonium sulfate) is an intravenous and oral broad-spectrum antifungal licensed in the European Union (EU) for the treatment of adult patients with:.

cresemba.fr

Cresemba SMPC

Veuillez vous connecter ci-dessous. Avec vos identifiants DocCheck. Accès libre pour les professionnels de la santé. Mot de passe oublié? Mot de passe oublié? Conditions d’utilisation et politique de confidentialité. Date de dernière révision: Juin 2016.

cresemba.info

The domain www.cresemba.info is registered by NetNames

The domain name www.cresemba.info. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.

cresemba.it

Cresemba SMPC

L'accesso in basso con la vostra password DocCheck. Acceso libero per i professionisti della salute. Termini e Condizioni di Utilizzo. Depositato presso AIFA il 27/07/2016.